Clinical trial
Thalidomide and Prednisone Following Peripheral Stem Cell Transplantation in…
NCT00006890 · NCIC Clinical Trials Group, Other · Completed
Key facts
| NCT number | NCT00006890 |
|---|---|
| Title | Thalidomide and Prednisone Following Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma |
| Official title | A Randomized Phase II Dose Finding Study Of Thalidomide And Prednisone As Maintenance Therapy Following Autologous Stem Cell Transplant In Patients With Multiple Myeloma |
| Lead sponsor | NCIC Clinical Trials Group, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Myeloma and Plasma Cell Neoplasm |
| Intervention type | Drug |
| Interventions | prednisone, thalidomide |
| Enrollment | 67 |
| Start date | Jul 12, 2000 |
| Primary completion | May 3, 2002 |
| Completion | Dec 15, 2008 |
| First posted | Mar 8, 2004 |
| Last update posted | Apr 2, 2020 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: